The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,472
Compendium of physical activities: an update of activity codes and MET intensities
AINSWORTH, B. E., HASKELL, W. L., WHITT, M. C., IRWIN, M. L., SWARTZ, A. M., STRATH, S. J., O???BRIEN, W. L., BASSETT, D. R., SCHMITZ, K. H., EMPLAINCOURT, P. O., et al. (2000) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200009001-00009 · Cited by 8,497
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
Farrell, G. C., & Larter, C. Z. (2006) · Hepatology · doi:10.1002/hep.20973 · Cited by 2,414
Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
Miele, L., Valenza, V., La Torre, G., Montalto, M., Cammarota, G., Ricci, R., Mascianà, R., Forgione, A., Gabrieli, M. L., Perotti, G., et al. (2009) · Hepatology · doi:10.1002/hep.22848 · Cited by 1,434 · cited 1×
“The contribution of microflora in the progression of NAFLD is mainly based on increased hepatic oxidative stress due to the increased production of ethanol, and lipopolysaccharides in the intestinal lumen, and subsequent release of inflammatory cytokines in some inflammatory cells (5, 9).”
BackgroundRandomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
Promrat, K., Kleiner, D. E., Niemeier, H. M., Jackvony, E., Kearns, M., Wands, J. R., Fava, J. L., & Wing, R. R. (2010) · Hepatology · doi:10.1002/hep.23276 · Cited by 1,330
Musso, G., Gambino, R., Cassader, M., & Pagano, G. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.518623 · Cited by 1,293
Creely, S. J., McTernan, P. G., Kusminski, C. M., Fisher, F. M., Da Silva, N. F., Khanolkar, M., Evans, M., Harte, A. L., & Kumar, S. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00302.2006 · Cited by 1,043
Liver fibrosis in overweight patients
Ratziu, V., Giral, P., Charlotte, F., Bruckert, E., Thibault, V., Theodorou, I., Khalil, L., Turpin, G., Opolon, P., & Poynard, T. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70364-7 · Cited by 973
Li, Z., Yang, S., Lin, H., Huang, J., Watkins, P. A., Moser, A. B., DeSimone, C., Song, X.-Y., & Diehl, A. M. (2003) · Hepatology · doi:10.1053/jhep.2003.50048 · Cited by 930
Adams, L. A., Sanderson, S., Lindor, K. D., & Angulo, P. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.09.012 · Cited by 911
Yang, S. Q., Lin, H. Z., Lane, M. D., Clemens, M., & Diehl, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2557 · Cited by 810
Ginger—An Herbal Medicinal Product with Broad Anti-Inflammatory Actions
Grzanna, R., Lindmark, L., & Frondoza, C. G. (2005) · Journal of Medicinal Food · doi:10.1089/jmf.2005.8.125 · Cited by 778
Yadav, H., Jain, S., & Sinha, P. R. (2007) · Nutrition · doi:10.1016/j.nut.2006.09.002 · Cited by 587
Bacterial Infections, Sepsis, and Multiorgan Failure in Cirrhosis
Tandon, P., & Garcia-Tsao, G. (2008) · Seminars in Liver Disease · doi:10.1055/s-2008-1040319 · Cited by 551
Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease
Hamaguchi, M. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i10.1579 · Cited by 542
Thoma, C., Day, C. P., & Trenell, M. I. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.06.010 · Cited by 523
Epidemiology and Natural History of NAFLD and NASH
Ong, J. P., & Younossi, Z. M. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.009 · Cited by 457
Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis
Malaguarnera, M., Vacante, M., Antic, T., Giordano, M., Chisari, G., Acquaviva, R., Mastrojeni, S., Malaguarnera, G., Mistretta, A., Li Volti, G., et al. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1887-4 · Cited by 455
Beneficial Effects of a Probiotic VSL#3 on Parameters of Liver Dysfunction in Chronic Liver Diseases
Loguercio, C., Federico, A., Tuccillo, C., Terracciano, F., D'Auria, M. V., De Simone, C., & Blanco, C. D. V. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000165671.25272.0f · Cited by 449
Gut–liver axis: The impact of gut microbiota on non alcoholic fatty liver disease
Compare, D., Coccoli, P., Rocco, A., Nardone, O. M., De Maria, S., Cartenì, M., & Nardone, G. (2012) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2012.02.007 · Cited by 446
Ma, X., Hua, J., & Li, Z. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.05.025 · Cited by 415
Thomson, M., Al-Qattan, K. K., Al-Sawan, S. M., Alnaqeeb, M. A., Khan, I., & Ali, M. (2002) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2002.0441 · Cited by 398
Nonalcoholic Fatty Liver Disease: Cytokine-Adipokine Interplay and Regulation of Insulin Resistance
Tilg, H., & Hotamisligil, G. S. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.05.054 · Cited by 384
Langner, E., Greifenberg, S., & Gruenwald, J. (1998) · PubMed · Cited by 297
Valenti, L., Fracanzani, A. L., Dongiovanni, P., Santorelli, G., Branchi, A., Taioli, E., Fiorelli, G., & Fargion, S. (2002) · Gastroenterology · doi:10.1053/gast.2002.31065 · Cited by 289
dela Peña, A., Leclercq, I., Field, J., George, J., Jones, B., & Farrell, G. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.09.004 · Cited by 287
Habib, S. H. M., Makpol, S., Hamid, N. A. A., Das, S., Ngah, W. Z. W., & Yusof, Y. A. M. (2008) · Clinics · doi:10.1590/s1807-59322008000600017 · Cited by 283
Effect of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats
Bhandari, U., kanojia, R., & Pillai, K. K. (2005) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.11.011 · Cited by 276
Velayudham, A., Dolganiuc, A., Ellis, M., Petrasek, J., Kodys, K., Mandrekar, P., & Szabo, G. (2009) · Hepatology · doi:10.1002/hep.22711 · Cited by 263
Arablou, T., Aryaeian, N., Valizadeh, M., Sharifi, F., Hosseini, A., & Djalali, M. (2014) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2014.880671 · Cited by 228
Health benefits and health claims of probiotics: bridging science and marketing
Rijkers, G. T., de Vos, W. M., Brummer, R.-J., Morelli, L., Corthier, G., & Marteau, P. (2011) · British Journal of Nutrition · doi:10.1017/s000711451100287x · Cited by 223
Iacono, A., Raso, G. M., Canani, R. B., Calignano, A., & Meli, R. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.10.002 · Cited by 192
Toll-Like Receptors in Liver Fibrosis: Cellular Crosstalk and Mechanisms
Yang, L., & Seki, E. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00138 · Cited by 176
Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?
Larter, C. Z., & Farrell, G. C. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.11.030 · Cited by 169
Lee, T.-Y., Lee, K.-C., Chen, S.-Y., & Chang, H.-H. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.160 · Cited by 160
Mozaffari–Khosravi, H., Talaei, B., Jalali, B. A., Nadjarzadeh, A., & Mozayan, M. R. (2014) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2013.12.017 · Cited by 156
Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies
Al-Attas, O. S., Al‐Daghri, N. M., Al-Rubeaan, K. A., da Silva, N. F., Sabico, S., Kumar, S., McTernan, P. G., & Harte, A. L. (2009) · Cardiovascular Diabetology · doi:10.1186/1475-2840-8-20 · Cited by 151
Probiotics and gut health: A special focus on liver diseases
Gratz, S. W., Mykkanen, H., & El-Nezami, H. S. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i4.403 · Cited by 145
Nardone, G., Compare, D., Liguori, E., Mauro, V., Rocco, A., Barone, M., Napoli, A., Lapi, D., Iovene, M. R., & Colantuoni, A. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00188.2010 · Cited by 94
Potential efficacy of ginger as a natural supplement for nonalcoholic fatty liver disease
Sahebkar, A. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i2.271 · Cited by 90
Zingiber officinale acts as a nutraceutical agent against liver fibrosis
Motawi, T. K., Hamed, M. A. A., Shabana, M. H., Hashem, R. M., & Naser, A. F. A. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-40 · Cited by 89
Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease
Eslamparast, T., Eghtesad, S., Poustchi, H., & Hekmatdoost, A. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v7.i2.204 · Cited by 77
Self-citationTransient elastography in non-alcoholic fatty liver disease
Abenavoli, L., & Beaugrand, M. (2012) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31021-x · Cited by 61
Metabolomics of Ginger Essential Oil against Alcoholic Fatty Liver in Mice
Liu, C.-T., Raghu, R., Lin, S.-H., Wang, S., Kuo, C., Tseng, Y. J., & Sheen, L. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf403523g · Cited by 55
Bardi, D. A., Halabi, M. F., Abdullah, N. A., Rouhollahi, E., Hajrezaie, M., & Abdulla, M. A. (2013) · BioMed Research International · doi:10.1155/2013/918460 · Cited by 53
Braddick, H. J. J. (1969) · Nature · doi:10.1038/224391a0 · Cited by 50
Fibroscan for assessing liver fibrosis: An acceptable alternative for liver biopsy
Malekzadeh, R., & Poustchi, H. (2011) · Hepatitis Monthly · Cited by 31
Self-citationMalekzadeh, R., & Poustchi, H. (2011) · PubMed · Cited by 31
Self-citationRecent advances in dietary supplementation, in treatingnon-alcoholic fatty liver disease
Tannaz, Eslamparast, Sareh, Eghtesad, Hossein, H., Poustchi, Azita, A., & Hekmatdoost (2015) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 28
Cited by
Effects of probiotics, prebiotics, and synbiotics on human health
Markowiak, P., & Śliżewska, K. (2017) · Nutrients · doi:10.3390/nu9091021 · Cited by 2,401
“It was found that supplementation with the synbiotic resulted in the inhibition of NF-κB (nuclear factor κB) and reduced production of TNF-α (tumour necrosis factor α) [188].”
Swanson, K. S., Gibson, G. R., Hutkins, R., Reimer, R. A., Reid, G., Verbeke, K., Scott, K. P., Holscher, H. D., Azad, M. B., Delzenne, N. M., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0344-2 · Cited by 2,196
ESPEN guideline on clinical nutrition in liver disease
Plauth, M., Bernal, W., Dasarathy, S., Merli, M., Plank, L. D., Schütz, T., & Bischoff, S. C. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.12.022 · Cited by 674
The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD)
Safari, Z., & Gérard, P. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03011-w · Cited by 502
Gut Microbiota and Complications of Type-2 Diabetes
Iatcu, C. O., Steen, A., & Covasa, M. (2021) · Nutrients · doi:10.3390/nu14010166 · Cited by 418
Metadata
- Authors
- Eslamparast, T., Poustchi, H., Zamani, F., Sharafkhah, M., Malekzadeh, R., & Hekmatdoost, A.
- Venue
- The American Journal of Clinical Nutrition
- Publisher
- Elsevier BV
- Published
- 2014-03
- Volume
- 99
- Issue
- 3
- Pages
- 535-542
- ISSN
- 0002-9165 (ISSN-L)
- OpenAlex
- W2114992666
- Cited by
- 405
- References
- 52
- FWCI
- 18.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.